Viewing Study NCT00775502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-05-17 @ 12:00 PM
Study NCT ID: NCT00775502
Status: TERMINATED
Last Update Posted: 2024-04-25
First Post: 2008-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
Sponsor: Kyowa Kirin Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple myeloma View
None GM-2 ganglioside View
None monoclonal antibody View
None Potelligent design View
None Treatment of subjects who have failed previous treatment View